All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mursejohn1 on TikTok · 55s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @mursejohn1's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:01Alright, let's talk about a couple other myths with TRT.
  2. 0:06First one that you hear a lot is, it's going to give you Royce and Lillina.
  3. 0:10All we are doing with TRT is optimizing your testosterone to the best of the normal limits.
  4. 0:18With that being said, it will decrease depression, decrease anxiety, improve sleep, improve motivation,
  5. 0:25improve confidence.
  6. 0:27No Royce rage.
  7. 0:28No Royce rage.
  8. 0:29I'm sorry guys.
  9. 0:30That one's about.
  10. 0:31Another one is, when you start you can't stop.
  11. 0:34That's not true either.
  12. 0:35Only unfortunate downside is you will go back down to pre TRT levels.
  13. 0:40I don't know what to tell you guys, but you can stop if you need to or want to.
  14. 0:45Anyway, any questions, any myths, any concerns you're thinking about?
  15. 0:48You want to hear?
  16. 0:49Shoot a message.
  17. 0:50Give us a call.
  18. 0:51Talk to you.
  19. 0:52Bye again.

@mursejohn1's TRT claims about aggression and stopping treatment

Jmrachina

TikTok creator

15.3K viewsWatch on TikTok

Quick answer

TRT is an FDA-regulated treatment for confirmed hypogonadism, defined by the Endocrine Society as testosterone below 300 ng/dL on two morning measurements with accompanying symptoms. The creator's claims about mood improvement align with published evidence in this population, particularly Snyder et al. (2016, NEJM) and Zarrouf et al. (2009, Journal of Psychiatric Practice). However, stopping TRT after extended use requires structured medical oversight due to hypothalamic-pituitary-gonadal axis suppression, which the video did not address adequately.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @mursejohn1's TRT claims about aggression and stopping treatment, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@mursejohn1's TRT claims about aggression and stopping treatment should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@mursejohn1's TRT claims about aggression and stopping treatment" from Jmrachina. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: TRT is an FDA-regulated treatment for confirmed hypogonadism, defined by the Endocrine Society as testosterone below 300 ng/dL on two morning measurements with accompanying symptoms.

The reason this review is not generic is the source wording and the canonical claim label "trt myth trt leads to aggressive behavior or roid rage tru." In this clip, the useful excerpt is: "Alright, let's talk about a couple other myths with TRT." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Endocrine Society requires two fasting morning blood draws below 300 ng/dL plus clinical symptoms before recommending TRT, not self-reported low energy or motivation alone (Bhasin et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

TRT is an FDA-regulated treatment for confirmed hypogonadism, defined by the Endocrine Society as testosterone below 300 ng/dL on two morning measurements with accompanying symptoms.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • TRT is an FDA-regulated treatment for confirmed hypogonadism, defined by the Endocrine Society as testosterone below 300 ng/dL on two morning measurements with accompanying symptoms. The creator's claims about mood improvement align with published evidence in this population, particularly Snyder et al. (2016, NEJM) and Zarrouf et al. (2009, Journal of Psychiatric Practice). However, stopping TRT after extended use requires structured medical oversight due to hypothalamic-pituitary-gonadal axis suppression, which the video did not address adequately.
  • Aggression at therapeutic TRT doses is not supported by clinical evidence. Studies linking testosterone to aggression involve supraphysiologic doses, not medical replacement therapy (Tricker et al., 1996, Psychoneuroendocrinology).
  • The Endocrine Society requires two fasting morning blood draws below 300 ng/dL plus clinical symptoms before recommending TRT, not self-reported low energy or motivation alone (Bhasin et al., 2018, JCEM).

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Aggression at therapeutic TRT doses is not supported by clinical evidence. Studies linking testosterone to aggression involve supraphysiologic doses, not medical replacement therapy (Tricker et al., 1996, Psychoneuroendocrinology).
  • The Endocrine Society requires two fasting morning blood draws below 300 ng/dL plus clinical symptoms before recommending TRT, not self-reported low energy or motivation alone (Bhasin et al., 2018, JCEM).
  • Mood and depression improvements from TRT are real in confirmed hypogonadal men. A meta-analysis of 7 studies found significant antidepressant effects compared to placebo (Zarrouf et al., 2009, Journal of Psychiatric Practice).
  • Stopping TRT is medically possible but triggers HPG axis recovery, which is not instantaneous and may leave testosterone below pre-treatment levels for weeks to months, depending on treatment duration.
  • TRT may worsen sleep apnea in men already at risk. Patients with obesity or snoring history should be screened before starting, as the video does not mention this real contraindication.
  • Benefits like improved libido, energy, and mood are most robust in men with testosterone below 230 ng/dL. Men in the low-normal range showed smaller or inconsistent benefits across the Testosterone Trials (Snyder et al., 2016, NEJM).
  • No TRT formulation, including injections, gels, or pellets, is interchangeable without a provider adjusting monitoring protocols. Formulation choice affects absorption, peak levels, and side effect profile.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @mursejohn1 actually say?

The creator, who identifies as a nurse, made two core claims: first, that TRT does not cause aggression because it only "optimizes testosterone to the best of the normal limits," and second, that stopping TRT is possible, though testosterone will return to pre-treatment baseline levels. These are reasonable starting points for a public education video, but they gloss over some real nuance that patients deserve to hear.

The aggression claim is framed confidently, with repeated reassurances of "no Roid rage, no Roid rage." The stopping claim is handled more carefully, with an honest acknowledgment that you will return to where you started. Both claims are worth examining against the actual clinical literature before you take TikTok as your medical reference.

Does the science back this up?

Mostly, yes, on aggression, with important caveats. The "roid rage" association comes primarily from studies of supraphysiologic doses, meaning levels far above the normal range, often in the context of anabolic steroid abuse rather than medically supervised TRT. The creator is broadly correct that restoring testosterone to physiologic levels does not reliably produce aggression.

A 2016 randomized controlled trial by Snyder et al. published in the New England Journal of Medicine found mood improvements in older hypogonadal men on TRT, not mood deterioration. A meta-analysis by Zarrouf et al. (2009, Journal of Psychiatric Practice) found TRT significantly reduced depressive symptoms in hypogonadal men. That tracks with the creator's claim that TRT can "decrease depression, decrease anxiety, improve sleep, improve motivation." Those benefits are documented, though individual responses vary and TRT is not a blanket antidepressant.

On stopping: the claim that testosterone returns to pre-TRT levels is accurate for most patients, but the timeline and degree of recovery depend heavily on how long someone has been on treatment and their baseline hypothalamic-pituitary-gonadal axis function.

What did they get wrong (or right)?

They got the broad strokes right, but oversimplified in ways that could mislead viewers. Saying TRT "will decrease depression, decrease anxiety, improve sleep" as near-certainties is too strong. These are common outcomes in hypogonadal men, but the evidence is strongest in men with confirmed low testosterone. For men in the low-normal range, the benefit picture is murkier. The Testosterone Trials (Snyder et al., 2016, NEJM) showed modest mood benefits, not dramatic transformation for everyone.

The stopping claim needs more context. For men who have been on TRT for extended periods, natural testosterone production, driven by the hypothalamic-pituitary-gonadal axis, can be suppressed. Recovery after stopping is not guaranteed to be fast or complete, particularly in older men or those with primary hypogonadism. Saying simply "you can stop if you need to or want to" without mentioning testicular suppression or the need for medical supervision during discontinuation is an incomplete picture.

No false claims were made outright. But "optimizing testosterone to the best of the normal limits" is not how TRT always works in practice. Target ranges vary by provider, formulation, and individual patient factors.

What should you actually know?

Aggression from TRT at therapeutic doses is not well-supported by clinical evidence. The studies that link testosterone to aggression generally involve supraphysiologic doses used in non-medical contexts. That said, individual neuropsychiatric responses to hormonal changes can vary, and patients with pre-existing mood conditions should be monitored.

If you are considering TRT, a formal diagnosis of hypogonadism matters. The Endocrine Society guidelines (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommend TRT only for men with consistently low testosterone confirmed on at least two morning blood draws, combined with clinical symptoms. Self-diagnosing "low T" from a TikTok video is not the same as a clinical evaluation.

Stopping TRT is a real option, but it should be done with medical guidance. Abrupt discontinuation after prolonged use can result in a period of below-baseline testosterone while the HPG axis recovers. Some men use post-cycle protocols to support recovery, though evidence on these approaches in TRT contexts specifically, rather than anabolic steroid contexts, is limited.

  • Mood benefits from TRT are real but strongest in men with confirmed hypogonadism.
  • "Roid rage" at therapeutic doses is not supported by clinical evidence.
  • Stopping TRT requires medical supervision, not just a decision to quit.
  • Benefits like improved sleep and motivation are documented but not universal.

Our overall read

This video is more accurate than most TRT content floating around TikTok. The creator avoids dosing advice, does not make disease-cure claims, and acknowledges a real downside of stopping. The core messaging on aggression is defensible. Where it falls short is in the confidence of the mood benefit claims and the oversimplification of what stopping TRT actually involves for your body. A nurse should know that "you can stop if you need to" is incomplete without mentioning HPG axis suppression. Give credit where it is due, but fill in the gaps before making any decisions.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jmrachina · TikTok creator

15.3K views on this video

Myth: TRT leads to aggressive behavior or "roid rage." - Truth: While extremely high levels of testosterone can lead to mood swings, TRT aims to restore testosterone to normal levels, which typically

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about aggression at therapeutic trt doses?

Aggression at therapeutic TRT doses is not supported by clinical evidence. Studies linking testosterone to aggression involve supraphysiologic doses, not medical replacement therapy (Tricker et al., 1996, Psychoneuroendocrinology).

What does the video say about the endocrine society requires two fasting morning blood draws below?

The Endocrine Society requires two fasting morning blood draws below 300 ng/dL plus clinical symptoms before recommending TRT, not self-reported low energy or motivation alone (Bhasin et al., 2018, JCEM).

What does the video say about mood?

Mood and depression improvements from TRT are real in confirmed hypogonadal men. A meta-analysis of 7 studies found significant antidepressant effects compared to placebo (Zarrouf et al., 2009, Journal of Psychiatric Practice).

What does the video say about stopping trt?

Stopping TRT is medically possible but triggers HPG axis recovery, which is not instantaneous and may leave testosterone below pre-treatment levels for weeks to months, depending on treatment duration.

What does the video say about trt may worsen sleep apnea in men already at risk.?

TRT may worsen sleep apnea in men already at risk. Patients with obesity or snoring history should be screened before starting, as the video does not mention this real contraindication.

What does the video say about benefits like improved libido, energy,?

Benefits like improved libido, energy, and mood are most robust in men with testosterone below 230 ng/dL. Men in the low-normal range showed smaller or inconsistent benefits across the Testosterone Trials (Snyder et al., 2016, NEJM).

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jmrachina, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.